In a report issued on June 6, David Larsen from BTIG reiterated a Buy rating on Healthequity (HQY – Research Report), with a price target of $85.00. The company's shares closed last Thursday at $63.10. According to TipRanks.com, Larsen has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -8.7% and a 34.7% success rate. Larsen covers the Technology sector, focusing on stocks such as Health Catalyst, American Well, and Sharecare. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Healthequity with a $77.82 average price target, a 21.9% upside from current levels.
https://www.tipranks.com/news/blurbs/healthequity-hqy-gets-a-buy-rating-from-btig?utm_source=advfn.com&utm_medium=referral